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The human Ia or class II antigens are determined by the HLA-DR region within 
the  human  major histocompatibility complex  (MHC)  on  chromosome six  and  are 
borne on molecules composed of two noncovalently associated glycoprotein chains of 
33,000-34,000  daltons  (a chain)  and 28,000-30,000  daltons (fl chain).  Recent studies 
(1-4)  using  both  alloantisera  and  monoclonal  antibodies  have  documented  the 
presence on HLA-DR homozygous cell lines of two a  chains and two fl chains which 
combine to  form at  least  two  Ia molecules.  The  data  presented  here establish  the 
existence  of a  third  structurally  distinct  Ia fl chain  on  HLA-DR  homozygous cell 
lines. 
Materials and Methods 
Cells.  The following B lymphoblastoid cell lines were obtained from the Human Genetic 
Mutant Cell Repository, Camden, N  J: PGF(GM3107), HLA-A3,A3; B7,B7; DR2,DR2; MB1; 
MT1; Te21; and MSTI(GM3161), HLA-A3,A3; B7,BT; DR2,DR2; MB1; MT1; Te21. The 
cell  line Swei,  HLA-A29,A29; B40,B40;  DR5,DR5;  MB3;  MT2, MT4; Te22, was obtained 
from Dr. John Hansen. The cell line BK types as HLA-A2, A-unidentified;  B49,B51; DR 1  ,DR5; 
MB1,MB3; MT1,MT2,MT4. The cell line MAR types as HLA-A2,A3; B18,B45;  DR2,DR4; 
MB 1,MB3; MT1,MT3. The cells were maintained as previously described (4). 
Preparation of Radiolabeled Antigens.  Class II antigens were radiolabeled with 35S-methionine 
(700-1300 Ci/mM, Amersham, Arlington Heights, IL) and immunoprecipitated with ailoan- 
tisera as previously reported (4). 
Antisera.  A summary of the serologically and immunochemically detected specificities  of 
the alloantisera, defined as previously described (4), can be found in Table I. 
Two-dimensional (2-D)  Gel Electrophoresis.  2-D gel electrophoresis was performed according 
to the method of O'Farrell (5) with some modifications as previously described (4). The first 
dimension separation by isoelectric  focusing (IEF) was performed in 5 ×  200-mm cylindrical 
gels, after which the IEF gels were cut into two pieces  that contained the a  and ~8 chains, 
respectively.  Each piece was applied to a separate sodium dodecyl sulfate-polyacrylamide  slab 
gel. 
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TABLE  I 
Alloantiserum  Laboratory of origin  Serologically defined specificity  Chemically defined specificity 
DA6*  Fuller  DR5 +  Te22~:  DR5 +  Te22 +  MT2 
Absorbed DA6§  Fuller  Not tested  DR5 
Ia- 172  Mann  MT2  MT2 
MGH88B  Fuller  MT4  MT4 
Bana.szak[[  Duquesnoy  DR2  DR2 
Dobbe  I  Duquesnoy  MBI/MTI +  DRI  MB1/MT1  +  DRI 
MGH 72  Fuller  MB 1/MT 1  MB 1/MT 1 
Ia-715"*  Mann  MBI/MT1  MBI/MTI 
Pohl  Rodey  DR1 +  DR2  DRI +  Te21 
* Serum 1225 in the Eighth International Histocompatibility Workshop (8W1225). 
:~ At 1:10 dilution. 
§ Details of absorption and immunochemical analysis previously reported (4). 
]l 7W154. 
¶ 8W119. 
** 8W567. 
Results 
2-D  Gel  Electrophoresis.  A  ~S-methionine-labeled  antigen  preparation  of  the 
DR I,DR5  heterozygous cell  line,  BK,  was  immunoprecipiated  with  serum  DA6, 
which had been absorbed with DR3 and DR4 cells (absorbed DA6), serum Ia-172, 
and  serum  MGH88B;  the  precipitated material  was  analyzed by 2-D  gels.  The fl 
chain portions of these gels are shown in Fig.  I. The fl chain patterns of DA6 and Ia- 
172 consist of a heterogeneous set of nine spots as previously reported (4). The fl chain 
pattern  of MGH88B  consists  of at  least  four  spots  (a  fifth  more  basic  spot  is 
occasionally seen)  which are a  subset  of the DA6 and Ia-172 fl patterns.  Based on 
these fl chain  patterns,  we  have  previously reported the  existence of at  least  two 
structurally distinct fl chains on DR5 cells; one chain (previously referred to as L2) 
consisted  of the  four spots  precipitated  by  MGH88B,  whereas  the  other fl  chain 
(previously referred to as L1) appeared to consist of the spots precipitated by DA6 
and  Ia-172,  but  not by MGH88B  (4).  However, {he fl pattern precipitated by the 
absorbed DA6 serum reveals the absence of two of the more basic spots precipitated 
by DA6 and Ia-172, but not by MGH88B. This result indicates that the portion of 
the  fl  chain  pattern  that  is  unique  to  DA6  and  Ia-172  actually  consists  of two 
structurally distinct fl chains. 
To establish a basis for uniform nomenclature, we will designate the three fl chains 
ill, f12, and fin based on the isoelectric point  (pI) of the most acidic spot  in each fl 
chain. The fl chain whose most acidic spot is most acidic relative to the most acidic 
spots of the other two fl chains will be designated ill, whereas the fl chain whose most 
acidic spot  is relatively most basic will be designated fla.  The fl chain whose most 
acidic spot has a pI intermediate between the most acidic spots of fll and fla will be 
designated f12. Therefore, the fl chain precipitated only by MGH88B is fll (hatched 
spots), the fl chain precipitated by absorbed DA6, but not by MGH88B, is f12 (open 
spots),  and  the fl chain  precipitated  by DA6  and  Ia-172,  but  not  precipitated by 
absorbed  DA6  or  MGH88B  is  fla  (closed spots).  There is  some  molecular weight 
heterogeneity among the three fl chains; the spots of  fix have a slightly lower molecular 
weight than the spots of f12. The most basic spot of fla has the same pI as the most 
basic  spot  of ill;  however,  the  two  spots  are  separable  because  of a  very slight 
difference in molecular weights. The most acidic spot of fla has the same molecular 
weight as the most basic spot of f12; however, the two spots are separable because of 
a  very slight  difference in pI.  Examination of the intervals between the spots  that 654  KARR  ET  AL.  BRIEF  DEFINITIVE  REPORT 
Fro.  1.  Fluorographs of 2-D gels of fl chains precipitated from a aSS-methionine-labeled antigen 
preparation of the BK cell line (DR 1,DR5)  by sera DA6, absorbed DA6, Ia-172, and MGH88B are 
shown at  the  left.  Schematic  representations of the  spots  in  each  gel  are  shown  at  the  right. 
Schematic representations of the spots that comprise ill, fl2, and fls are shown at the bottom. Arrows 
indicate the two spots offls, which are precipitated by sera DA6 and Ia-172, but not by the absorbed 
DA6 serum. The two dark spots with <25,000 mol wt at the acidic end of some fl chain gels are an 
inconsistent finding and therefore do not appear to be related to the B chain spots. The row of spots 
at 44,000 daltons with MGH88B most likely represents HLA class I molecules. 
FIc.  2.  Fluorographs of 2-D gels of fl chains immunoprecipitated from a anS-methionine-labeled 
antigen preparation of the DR2 homozygous cell line, MST1, by sera Dobbe, Banaszak, MGH72, 
and Pohl are shown at left and schematic representations of the spots in each gel are shown at right. 
See legend to Fig.  1. 
comprise each fl chain provides additional  confirmation  that the spots of each fl chain 
are more closely related to each other than  to the spots of another  fl chain. The  spots 
of each distinct fl chain  are separated  from each  other  by some  integral multiple  of 
the  shortest  interval  between  two  spots  of that  fl  chain.  For  example,  the  interval 
between the middle spot offl2 and the most acidic spot offl2 is the same as the interval KARR  ET  AL.  BRIEF  DEFINITIVE REPORT  655 
between the middle spot and the most basic spot. The shortest interval, or charge 
unit, is unique for each of the three fl chains. 
In summary, serum MGH88B precipitated only ill. The fl chain pattern of absorbed 
DA6 contains fll and f12 and the/3 chain patterns of unabsorbed  DA6 and Ia-172 
include /3a, f12, and  fla.  These  relationships  are  depicted  schematically in  Fig.  1. 
Identical /3  chain patterns were observed  when these sera  were used  to  isolate Ia 
molecules from an antigen preparation of the DR5 homozygous cell line, Swei. The 
a  chain patterns precipitated  from DR5  antigen preparations by serum  DA6  and 
serum Ia-172 (4) and by the absorbed DA6 serum (unpublished observations) consist 
of both al and as (previously referred to as H1 and H2, respectively), whereas the a 
chain pattern of serum MGH88B consists only of a2 (4). 
To determine whether the demonstration of a  third human Ia/3 chain could be 
generalized, a  ~S-methionine-labeled antigen preparation of the DR2  homozygous 
cell line, MST1, was immunoprecipitated with sera Dobbe, Banaszak, MGH72, and 
Pohl;  the  precipitated  material  was  then  compared  by  2-D  gels  (Fig.  2).  Serum 
Banaszak precipitated  a  complex fl chain  pattern  of eleven  spots.  Serum  Dobbe 
precipitated  only eight of the same spots precipitated  by Banaszak, whereas  Pohl 
precipitated a more restricted subset of the Banaszak/3 pattern. MGH72 precipitated 
a  pattern  that was qualitatively the same as the Dobbe pattern. These complex/3 
chain  patterns  can  be  explained  by  postulating no  fewer  than  three  structurally 
distinct/3 chains, which we have labeled fix, /32, and/3s using the same criteria as 
described above./31 (five hatched spots) is precipitated by all four sera; however, Pohl 
isolates /31  alone.  /32  (three  open  spots)  is  precipitated  by Dobbe,  Banaszak,  and 
MGH72, but not by Pohl./3s is precipitated only by Banaszak. Compared with the 
three/3 chains from DR5 cells, there is less molecular weight heterogenity among the 
three/3 chains from DR2 cells. 
According to this construct, the complex/3 chain pattern precipitated by Banaszak 
includes/31,/32, and/33. The Dobbe/3 chain pattern contains/3x and/32, but lacks/3s. 
Quantitatively similar amounts of/31 are precipitated by both Dobbe and Banaszak; 
however, Dobbe precipitated more/32 than Banaszak. Serum Ia-715 precipitated a/3 
chain  pattern  identical  to  Dobbe  (data  not  shown).  Serum  MGH72  precipitated 
primarily/32, but also a small amount of/31.  Serum Pohl precipitated only fla. These 
relationships are depicted schematically in Fig. 2. Again, examination of the intervals 
between the spots that comprise each/3 chain confirms that the spots of each/3 chain 
are more closely related to each other than to the spots of the other/3 chains;  the 
shortest interval is unique for each of the three/3 chains. Identical/3 chain patterns 
were  observed  when  these  sera  were  used  to  isolate  Ia  molecules  from  antigen 
preparations of another DR2 homozygous cell line, PGF, and a  DR2 heterozygous 
cell line, MAR  (data not shown). The a  chain patterns precipitated by Banaszak, 
Dobbe,  MGH72,  and  Pohl  consisted of al  and  variable  amounts of a2  (data  not 
shown) 
Discussion 
The  data  presented  here  document  for  the  first  time  the  existence  of a  third 
structurally  distinct  human  Ia  fl  chain.  The  use  of alloantisera,  which  contain 
antibodies  to  polymorphic  determinants  on  Ia  molecules,  provided  a  significant 
advantage in these studies because we were able to investigate the same antigens on 656  KARR ET AL.  BRIEF  DEFINITIVE REPORT 
both DR heterozygous and homozygous cell lines. In contrast, most anti-Ia monoclonal 
antibodies recognize monomorphic determinants and, therefore, cannot be used to 
isolate individual Ia molecules from DR heterozygous cell lines. 
The complex array of fl chain patterns precipitated from two HLA-DR2 homozy- 
gous cell lines and one HLA-DR2 heterozygous cell line by four alloantisera can be 
explained by the existence of no fewer than three structurally distinct fl chains, termed 
fix, f12, and fla. The two spots of fla were precipitated only by serum Banaszak. The 
existence of a  third fl chain was also demonstrated on both HLA-DR5 homozygous 
and heterozygous cell lines when two spots that were precipitated by serum DA6 and 
serum Ia-172 were not precipitated by the absorbed DA6 serum. The demonstration 
that  identical ill, f12, and fls patterns  are precipitated from DR5  homozygous and 
DR1,  DR5  heterozygous cell  lines,  coupled  with  the  observation  that  the  DR1- 
associated fl chains are distinct from the DR5-associated fl chains (data not shown) 
excludes the possibility that  the third fl chain is due to the lack of true HLA-DR 
homozygosity. The designations, fix, f12 and fin of fl chains isolated from DR2  and 
DR5 cells were assigned solely based on the pI of the most acidic spot of each fl chain; 
the  data  presented  here  do  not  allow  any  conclusions  about  possible  homology 
between, for example, the DR2 fll and the DR5 fla. There appears to be structural 
polymorphism of all three fl chains since none of the three fl chains from DR2 cells 
are structurally identical to any of the three fl chains from DR5 cells. 
Several studies  using both alloantisera  and  monoclonal antibodies have recently 
established the presence of two a  chains and two fl chains that combined to form two 
class II molecules on HLA-DR homozygous cells  (1-4).  Shackelford et  al.  (1)  also 
used alloantisera and 2-D gels to investigate the Ia molecules expressed by the DR2 
homozygous cell line, PGF. They found a total of 10 fl chain spots using a combination 
of sera. A DR2 alloantiserum precipitated a fl chain pattern consisting of seven spots. 
They postulated, but did not demonstrate, that  this pattern might represent two fl 
chains. Sera for the specificities MB 1, MT 1, DC 1, and LB 12, including serum Ia-715, 
which was used in the present study, precipitated a fl chain pattern of three spots that 
were  distinct  from  the  spots  precipitated  by  the  DR2  serum.  Although  we  have 
detected a similar total number of fl chain spots from DR2 antigen preparations, we 
found that  three anti-MB1/MT1  sera  (Dobbe, Ia-715,  and  MGH72)  precipitated, 
with some quantitative variation, a fl chain pattern consisting of seven spots (ill and 
f12). The reason for the differences between our results and those of Shackelford, et al. 
(1)  are  unclear,  but  these  observations  suggest  that  there  may  be  considerable 
heterogeneity among sera that define the same serologic specificity. 
An  impressive  degree  of homology  has  been  found  between  the  Ia  molecules 
determined by the murine and human MHC. Until recently, only two a  chains, A~ 
and E~, and two fl chains, A~ and EO, have been thought to comprise the murine I-A 
and  I-E  molecules.  However,  two  studies  have  suggested  that  there  may  be  two 
structurally distinct I-E molecules (and, therefore, presumably three Ia fl chains)  in 
some haplotypes  (6,  7).  Human  Ia molecules that  appear to be equivalent  to  the 
murine I-A and I-E molecules based on amino acid sequence homology have recently 
been isolated with monoclonal antibodies (3). Additional studies are now in progress 
to determine which of the three human Ia fl chains we have identified with allosera 
correspond to these human I-A or I-E equivalent molecules. 
Previous  data  (1-4)  from  several  groups  have  documented  that  at  least  two KARR ET AL.  BRIEF DEFINITIVE REPORT  657 
structurally distinct Ia a  and Ia fl chains are expressed on HLA-DR homozygous cell 
lines, whereas a  more recent study (8) postulated  the existence of at least seven Ia fl 
chains based on partial  amino acid sequence data. The data presented in this report 
demonstrate the existence of a third human Ia fl chain. This suggests that at least five 
separate genes control the expression of class II molecules on HLA-DR homozygous 
cell lines. 
Summary 
Previous studies have indicated that HLA-DR homozygous cell lines express two Ia 
a  and  Ia  fl  chains  that  combine  to  form  at  least  two  Ia  molecules.  This  report 
demonstrates by two-dimensional gel electrophoresis the existence of a third structur- 
ally distinct human Ia fl chain on DR2 and DR5 cell lines. This suggests that at least 
five separate  genes control the expression of Ia molecules on HLA-DR  homozygous 
cell lines. 
Received  for publication 22 April  1982. 
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